Showing results (1-10 of 359) with videos related to
Sort By:
Pageof 36
International Journal of Clinical Practice. Supplement|May 7, 2005
Ezetimibe-induced hyperlipidaemiaE Doherty, P J Lumb, G Chik, et al.International Journal of Clinical Practice|January 5, 2002
Comparison of therapy with simvastatin 80 mg and 120 mg in patients with familial hypercholesterolaemiaA S Wierzbicki, P J Lumb, G ChikInternational Journal of Clinical Practice|June 23, 2004
Effect of moxonidine on lipid subfractions in patients with hypertensionP J Lumb, Z McMahon, G Chik, et al.The American Journal of Cardiology|September 29, 2000
High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemiaA S Wierzbicki, P J Lumb, G Chik, et al.The American Journal of Cardiology|February 13, 2001
Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemiaA S Wierzbicki, P J Lumb, G Chik, et al.International Journal of Clinical Practice|February 29, 2000
Comparison of therapy with simvastatin 80 mg and atorvastatin 80 mg in patients with familial hypercholesterolaemiaA S Wierzbicki, P J Lumb, G Chik, et al.QJM : Monthly Journal of the Association of Physicians|January 11, 2000
Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemiasA S Wierzbicki, P J Lumb, Y Semra, et al.QJM : Monthly Journal of the Association of Physicians|January 24, 1998
Fenofibrate plus simvastatin therapy versus simvastatin plus cholestyramine therapy for familial hypercholesterolaemiaA S Wierzbicki, P J Lumb, J Cheung, et al.Hypertension (Dallas, Tex. : 1979)|November 18, 2000
Renin-angiotensin system polymorphisms and coronary events in familial hypercholesterolemiaA S Wierzbicki, M Lambert-Hammill, P J Lumb, et al.QJM : Monthly Journal of the Association of Physicians|July 17, 1998
High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemiaA S Wierzbicki, P J Lumb, Y K Semra, et al.Pageof 36